Variation in use of PROMs and geographical distribution in clinical trials of selected hematological diseases in Europe
Authors:
- Mercè CasesMCMercè Cases
- Attila ImreAttila Imre
- Rachel GilesRGRachel Giles
- Lis PugaLPLis Puga
- Maria PigginMPMaria Piggin
- Jan GeisslerJGJan Geissler
- Monica RacovitaMRMonica Racovita
- Susanna Leto di PrioloSPSusanna Leto di Priolo
- Lora Ruth WoguLWLora Ruth Wogu
- Albina Hyseni-BocolliAHAlbina Hyseni-Bocolli
- Kate MorganKMKate Morgan
- Dalma HosszúDHDalma Hosszú
Open Access
- 14 May 2026
- journal article
- Published by Elsevier in Blood Global Hematology
- Vol. 2 (3)
Abstract
No abstract availableFunding Information
- Roche
- Sanofi-Aventis Deutschland
- Servier Canada
- Swedish Orphan Biovitrum
- Takeda Pharmaceuticals International
- Johnson and Johnson
- Novartis
- Pfizer
- Boehringer Ingelheim
- Celgene
- Daiichi Sankyo Europe
- Eli Lilly and Company
- Amgen Nederland
- AstraZeneca Schweiz
- Bayer Fund
This publication has 27 references indexed in Scilit:
- Large Language Model Analysis of Reporting Quality of Randomized Clinical Trial ArticlesJAMA Network Open, 2025
- SEETrials: Leveraging large language models for safety and efficacy extraction in oncology clinical trialsInformatics in Medicine Unlocked, 2024
- Performance of two large language models for data extraction in evidence synthesisResearch Synthesis Methods, 2024
- Data extraction for evidence synthesis using a large language model: A proof‐of‐concept studyResearch Synthesis Methods, 2024
- The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022Applied Health Economics and Health Policy, 2023
- Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemiaJournal of Geriatric Oncology, 2022
- Patient-reported outcomes are under-utilised in evaluating supportive therapies in paediatric oncology – A systematic review of clinical trial registriesCritical Reviews in Oncology/Hematology, 2022
- Quantifying geographical accessibility to cancer clinical trials in different income landscapesESMO Open, 2022
- Capturing what matters: updating NICE methods guidance on measuring and valuing healthQuality of Life Research, 2022
- International guidance on the selection of patient-reported outcome measures in clinical trials: a reviewQuality of Life Research, 2020